A clinical resource on the nine-mechanism hair loss framework — the research, the evidence base, and the integrated protocol. Verify it against the literature yourself, then carry FLUFFY in your practice.
You already know the mechanism the market is built on: 5-alpha reductase converts testosterone to DHT, DHT binds androgen receptors in the dermal papilla, the follicle miniaturizes. Finasteride inhibits it; minoxidil extends anagen and improves perfusion. Between them, the standard of care addresses one to two of nine documented pathways.
The other seven run unopposed — PGD2 signaling (elevated 3× in balding scalp, independent of DHT), microbiome-driven inflammation, endocannabinoid dysregulation, oxidative follicle damage, sebum dysregulation, and structural nutrition deficiency. This is the mechanistic explanation for the plateau every clinician sees, and for the synchronized shed on discontinuation.
Then you've seen the ceiling — the patient who does everything right and still plateaus on monotherapy. The nine-mechanism framework isn't a replacement for what you know; it's the systematic map of the seven pathways the standard prescription never touches. Run the research prompts below against the literature. Verify it yourself. Then decide whether it belongs in your practice.
| 1 | DHT Conversion | 5-AR converts testosterone to DHT; androgen-receptor binding in the dermal papilla drives miniaturization. The one pathway standard care addresses. |
| 2 | PGD2 Signaling | Elevated 3× in balding scalp vs. hair-bearing (Science Translational Medicine, 2012). Independent miniaturization signal. Zero FDA-approved drugs address it. |
| 3 | Reduced Perfusion | Follicle starves as scalp vasculature deteriorates from tension, fibrosis, or medication effect. Anagen shortens. |
| 4 | Microbiome Disruption | Malassezia overgrowth drives chronic low-grade inflammation and amplifies DHT sensitivity at the follicular ostium. |
| 5 | Cytokine Inflammation | Systemic inflammatory cytokines disrupt the growth cycle directly — the mechanism behind post-illness and post-COVID diffuse shedding. |
| 6 | ECS Dysregulation | CB1/CB2/TRPV1 receptors regulate anagen entry/exit. Dysregulation drives premature catagen. No pharmaceutical engages it. |
| 7 | Oxidative Damage | H₂O₂ accumulation in aging follicles damages both hair and pigment cells. Copper-dependent enzymes are the primary defense. |
| 8 | Sebum Dysregulation | DHT-driven excess sebum feeds Malassezia and concentrates androgens at the ostium — amplifies mechanisms 1 and 4. |
| 9 | Structural Nutrition | Keratin synthesis requires ferritin >70, zinc, biotin, silica, sulfur. Deficiency caps output regardless of every other mechanism. |
Female, early 50s, referred as androgenetic pattern loss, prescribed topical minoxidil on a TSH-only thyroid screen. Complete workup: ferritin 31 (below keratin-synthesis threshold), incomplete thyroid picture on expanded panel, elevated hs-CRP. Three active mechanisms — structural nutrition, thyroid, and inflammatory — none addressed by the monotherapy she was on. Multi-mechanism protocol initiated against the full panel. The pattern is common; the workup that catches it is not.
Run these in ChatGPT or Gemini, in order, in one thread. They pull the credentialed evidence base so you can assess the framework against the published record yourself.
Configure the five fields to a patient presentation. We'll assemble a clinical research prompt for that case — paste it into the same AI thread.
Before you decide, do the math on your own practice. Set the three fields — we'll build a finished revenue-projection prompt with the FLUFFY economics already baked in. No typing.
You've reviewed the mechanisms and the evidence. If the nine-mechanism protocol fits your practice, Absolute Health makes FLUFFY available to licensed practitioners at wholesale — a complete-protocol offering your patients can't get from a telehealth subscription.
